Revalesio Corp — Form D/A

Revalesio Corp of TACOMA, WA, a company, filed a Form D amendment with the SEC on 2025-12-16. The offering totals $40.3M, of which $38.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
CHRIS FIBIGERDirectorTACOMA, WA
MATT IRELANDDirectorTACOMA, WA
JAMES NORDSTROMDirectorTACOMA, WA
ERIC RUSSELLDirectorTACOMA, WA
JANE TAYLORDirectorTACOMA, WA
BERT VAN DEN BERGHDirectorTACOMA, WA
GREG ARCHAMBEAUExecutive OfficerTACOMA, WA
Jeffrey SmithDirectorMARLBOROUGH, MA
ERIC RUSSELLExecutive OfficerTACOMA, WA
BERT VAN DEN BERGHExecutive OfficerTACOMA, WA
Troy AlsteadDirectorGig Harbor, WA
WILLIAM GALLACHERDirectorTACOMA, WA
LIAM GALLACHERDirectorCalgary, A0
TOM BUMOLDirectorTACOMA, WA
Scott WalchekDirectorSan Ramon, CA
JIM NORDSTROMDirectorTACOMA, WA
Lee HuntsmanDirectorSeattle, WA
MARSHA RUSSELLDirectorTACOMA, WA
BRUCE BUSKIRKExecutive OfficerTACOMA, WA
PATRICK CARUANADirectorTACOMA, WA
Scott WalcheckDirectorTacoma, WA
Karl BandlienDirectorTacoma, WA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-04-12D/A$30.6M$25.5M
2022-06-09D$15.0M$12.0M
2020-07-22D$26.8M$20.4M
2018-06-27D$12.0M$6.0M
2016-07-05D$14.0M$14.0M
2014-05-05D$40.0M$13.5M
2012-06-19D$20.0M$10.7M

More